Related Experiment Video
Updated: Jun 20, 2026
Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
Cephaeline promotes ferroptosis in breast cancer via p53/SLC7A11/GPX4 axis
Xiaohong Li1,2, Jinghan Yu1, Beibei Lin1
1The People's Hospital of Cangnan, The Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, China.
Background:
Cephaeline (CPL), a bioactive compound derived from the medicinal plant Ipecacuanha, has demonstrated inhibitory effects on several tumor types. Nevertheless, its role in breast cancer and the underlying molecular mechanisms remain largely unexplored.
Objectives:
This research aimed to investigate the anti-cancer potential of CPL in breast cancer cells.
Methods:
The IC50 of CPL was determined using the CCK-8 assay. Subsequently, the effects of CPL on cell migration and proliferation were assessed through wound healing (scratch) and colony formation assays, respectively. Additionally, MDA and GSH levels were quantified using ELISA, while ROS production was visualized via DHE staining. Intracellular iron content was measured using an iron assay kit. Furthermore, the expression levels of p53, SLC7A11, and GPX4 were evaluated using Western blot. All experiments were performed in triplicate and independently repeated at least three times, and data were analyzed using Student's t-test or one-way ANOVA, as appropriate.
Results:
CPL significantly inhibited the proliferation and viability of 4T1 and MDA-MB-231 breast cancer cells in a dose-dependent manner, with IC50 values of 38.89 nM and 50.29 nM, respectively, and concomitantly suppressed cell migration and colony formation at higher concentrations. It also increased intracellular MDA and ROS and downregulated GSH, SLC7A11 and GPX4, inducing ferroptosis. siRNA knockdown of p53 attenuated CPL's effects, indicating p53's key role in CPL's anti-cancer activity.
Conclusions:
This study provides evidence that CPL exerts anti-breast cancer effects by promoting ferroptosis through the p53/SLC7A11/GPX4 axis, highlighting its therapeutic potential as a novel agent for cancer treatment.
Insights
Cephaeline (CPL) shows anti-breast cancer effects by inducing ferroptosis, a cell death pathway. This compound targets the p53/SLC7A11/GPX4 axis, suggesting its potential as a novel cancer therapeutic agent.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cephaeline (CPL), a compound from Ipecacuanha, shows anti-tumor effects.
- Its specific role and mechanisms in breast cancer are not well understood.
Purpose of the Study:
- Investigate the anti-cancer potential of CPL in breast cancer cells.
- Elucidate the molecular mechanisms underlying CPL's effects.
Main Methods:
- Cell viability (CCK-8), migration (wound healing), and proliferation (colony formation) assays were used.
- Biochemical assays measured MDA, GSH, ROS, and intracellular iron.
- Western blot analyzed p53, SLC7A11, and GPX4 expression.
Main Results:
- CPL inhibited breast cancer cell proliferation, viability, migration, and colony formation.
- CPL induced ferroptosis by increasing MDA and ROS, and decreasing GSH, SLC7A11, and GPX4.
- p53 knockdown diminished CPL's anti-cancer effects, highlighting p53's crucial role.
Conclusions:
- CPL exhibits anti-breast cancer activity by inducing ferroptosis via the p53/SLC7A11/GPX4 pathway.
- CPL demonstrates therapeutic potential as a novel agent for breast cancer treatment.
Related Concept Videos
01:16Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
02:23Abnormal Proliferation